ENDO INTERNATIONAL for ENDO INTERNATIONAL
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Torts TOR
Issues relating to mass torts and class action reform.
Foreign entity interest: As the parent of Endo Pharmaceuticals Inc. Endo International, plc has interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRIAN MUNROE | — |
| ANDREW SCOTT | — |
Economics/Economic Development ECN
Issues relating to the expansion of jobs in New York state.
Foreign entity interest: As the parent of Endo Pharmaceuticals Inc. Endo International, plc has interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRIAN MUNROE | — |
| ANDREW SCOTT | — |
Taxation/Internal Revenue Code TAX
Issues relating to the Tax Cuts and Jobs Act H.R. 1 (115); issues relating to incentives for life sciences research; tax treatment of inverted companies; tax issues in mergers and acquisitions of US firms.
Foreign entity interest: As the parent of Endo Pharmaceuticals Inc. Endo International, plc has interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRIAN MUNROE | — |
| ANDREW SCOTT | — |
Copyright/Patent/Trademark CPT
Oversight of implementation of the America Invents Act; issues relating to patent settlements; patent reform; issues relating to misuse of the inter pares review process.
Foreign entity interest: As the parent of Endo Pharmaceuticals Inc. Endo International, plc has interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRIAN MUNROE | — |
| ANDREW SCOTT | — |
Health Issues HCR
Issues relating to prescription drug abuse; issues relating to incentives for tamper-resistant formulations; issues relating to FDA approvals of new drugs and generic drugs; issues related to the FDA; issues related to opioids; issues relating to Medicare Part D rebates; issues relating to the labeling of generic drugs; issues relating to products containing high doses of acetaminophen; issues relating to drug compounding; issues relating to removal of FDA unapproved products from the market; opioid abuse legislation; issues relating to prescription drug pricing; issues relating to illegal marketing of Phenobarbital; issues relating to FDA approval of Adrenalin.
Foreign entity interest: As the parent of Endo Pharmaceuticals Inc. Endo International, plc has interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRIAN MUNROE | — |
| ANDREW SCOTT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.